Surgical hair loss treatment option

 Hair loss treatment through surgery has become very common therapy in patients both male and female specifically androgenic alopecia. FPHL is a clinical ailment that usually occurs in women. The alopecia is called female androgenic alopecia in those women whose level of androgen hormone will become high and if alopecia occurs without an increase in androgen hormones is called FPHL. The therapeutical array of conventional female androgenic alopecia is the dispersed decrease of HF from the front vertical and parietal areas. According to Ludwig, this process is called ‘rarefaction’.  Female androgenetic alopecia is an increasing form of in decreasing HFs in women and usually has three stages: stage 1 which is mild, stage 2 which is moderate, and stage 3 which is chronic. Female androgenetic alopecia occurs in the following situations i.e., obdurate adrenarche syndrome, due to adrenal or tumor in ovaries, post-hysterectomy, and involute alopecia. FPHL can be diagnosed by examining the clinical history of a patient and doing some laboratory tests including dermatoscopy, tricho Scan, tricho Grams. If the disease is chronic then systemic antiandrogenic therapy should be performed. The most common problem in men is androgenic alopecia (AGA) and it is the most serious problem seen by many dermatologists. In androgenic alopecia or MPHL, the HF becomes small and less (there is the miniaturization of HF) and terminal HF becomes vellus like. The etiology of androgenic alopecia and MPHL is both hormonal and genetic.

Hair loss treatment through surgery is a revolutionized technique that provides effective therapy to patients having HF problems. The advanced interpretations in comprehending the aesthetics of damaged HFs and cosmetic HF restoration, HF anatomy and physiology, and the evolvement of microvascular surgical instruments have made futuristic progress in the correction of HFs. In addition to this, the current state of the art in restoration including graft size, site creation, packing density, and medical control of decreasing HFs also contributes to progress. The basic conviction of HRS is to make sure that physicians and patients must consider that reduction in HFs is progressive during the evaluation. The quality of donor HF is also a contributing factor that ensures successful surgery. The qualities o that should be kept under consideration include curl, shaft diameter, color, texture, follicular unit density, and the telogen/androgen ratio of the donor's HFs. These factors must be kept in the documented form to foresee the success of the transplant.

Hair loss treatment through surgery requires extensive time-consuming procedures. A usual ordinary session consists of 1500 to 2500 grafts requires 4 assistants and will last roughly about 6 to 7 hours. The procedure is performed by using a clean method with sterilized and biodegradable instruments. After surgery, the recipient sites and donor areas are usually not covered with a bandage, and around the time of surgery, antibiotics are not prescribed on a routine basis. Patients are instructed to keep their head elevated and ice cubes are used on forehead and donor areas to relieve any itching and pain, along with analgesics. Aloe ointment in the grafted region and gentle shampooing should be started approximately after 2 to 3 days of surgery. Mostly scars start fading in 8 to 10 days and gone by day 16, and donor sutures are removed on day 20. Although there are exceptions, most grafts go through a telogen process for the first three months before entering anagen. For 8 to 12 months after the operation, full growth and assessment of transplant outcomes cannot be accurately measured.

Hair loss treatment through surgery is becoming increasingly common, and the results that we can achieve today are very impressive, giving the operation a natural appearance when done correctly. Luckily, the chances of complications in restoration surgery are utterly low. Unfortunately, the written data of significant size, detailing the frequency of complications in large series is not available yet. However, the categories of complications found in patients have been well evaluated and can be classified into surgical and aesthetic complications. However, the classes of complications found in patients are well evaluated and might be classified into surgical and aesthetic complications. In recent applications, the prevalence of primary surgical complications is found to be but two to three and includes trauma, fistula in arteries and veins, tumor, blisters infection, death frontal, neurosensory alterations, and bruising. Primary aesthetic complications include poor growth of grafts, postsurgical effluvium, and unnatural appearance. The chances of poor growth range from 0% to 25%, but this number is highly subjective. These obstacles and other patient safety concerns have been under evaluation in detail elsewhere. Take your time and make proper research and choose the best hair transplant clinic for your procedure.